2014

Synthesis and characterization of new derivatives of alginic acid and evaluation of their iron (III)-crosslinked beads as potential controlled release matrices

mkhanfar, 645, Journal Article, , Synthesis and characterization of new derivatives of alginic acid and evaluation of their iron (III)-crosslinked beads as potential controlled release matrices. (2014). Pharmaceutical Development and Technology 19 (7), 856-867, 2014, 19, 856–867.

2014

Synthesis and characterization of new derivatives of alginic acid and evaluation of their iron (III)-crosslinked beads as potential controlled release matrices

mkhanfar, 645, Journal Article, , Synthesis and characterization of new derivatives of alginic acid and evaluation of their iron (III)-crosslinked beads as potential controlled release matrices. (2014). Pharmaceutical Development and Technology, 19, 856–867.

2014

Assessment of Vincristine safe preparation and administration in Riyadh hospitals

malfagih, 879, Presentation, , Assessment of Vincristine safe preparation and administration in Riyadh hospitals. (2014).

2014

Opposing changes in thoracic and abdominal aortic biomechanical properties in rodent models of vascular calcification and hypertension

isalman, 854, Journal Article, , Opposing changes in thoracic and abdominal aortic biomechanical properties in rodent models of vascular calcification and hypertension. (2014). American Journal of Physiology-Heart and Circulatory Physiology 307 (2 …, 2014, 307, H143–H151.

2014

Discovery of novel urokinase plasminogen activator (uPA) inhibitors using ligand-based modeling and virtual screening followed by in vitro analysis

mkhanfar, 645, Journal Article, , Discovery of novel urokinase plasminogen activator (uPA) inhibitors using ligand-based modeling and virtual screening followed by in vitro analysis. (2014). Journal of Molecular Modeling 20 (1), 1-15, 2014, 20, 2080.

2014

Sympathetic overactivity prevails over the vascular amplifier phenomena in a chronic kidney disease rat model of hypertension

oaladhami, 719, Journal Article, , Sympathetic overactivity prevails over the vascular amplifier phenomena in a chronic kidney disease rat model of hypertension. (2014). Physiological Reports 2 (11), E12205, 2014, 11(12205).

2013

Pharmacophore modeling, homology modeling, and in silico screening reveal mammalian target of rapamycin inhibitory activities for sotalol, glyburide, metipranolol, sulfamethizole, glipizide, and pioglitazone

mkhanfar, 645, Journal Article, , Pharmacophore modeling, homology modeling, and in silico screening reveal mammalian target of rapamycin inhibitory activities for sotalol, glyburide, metipranolol, sulfamethizole, glipizide, and pioglitazone. (2013). Journal of Molecular Graphics and Modelling, 42, 39–49.

2013

Pharmacophore modeling, homology modeling, and in silico screening reveal mammalian target of rapamycin inhibitory activities for sotalol, glyburide, metipranolol, sulfamethizole, glipizide, and pioglitazone

mkhanfar, 645, Journal Article, , Pharmacophore modeling, homology modeling, and in silico screening reveal mammalian target of rapamycin inhibitory activities for sotalol, glyburide, metipranolol, sulfamethizole, glipizide, and pioglitazone. (2013). Journal of Molecular Graphics and Modelling, 42, 39–49.

2013

Pharmacophore modeling, homology modeling, and in silico screening reveal mammalian target of rapamycin inhibitory activities for sotalol, glyburide, metipranolol …

mkhanfar, 645, Journal Article, , Pharmacophore modeling, homology modeling, and in silico screening reveal mammalian target of rapamycin inhibitory activities for sotalol, glyburide, metipranolol … (2013). Journal of Molecular Graphics and Modelling 42, 39-49, 2013.

2013

Protective activity of (1S, 2E, 4R, 6R, 7E, 11E)-2, 7, 11-cembratriene-4, 6-diol analogues against diisopropylfluorophosphate neurotoxicity: Preliminary structure–activity relationship and pharmacophore modeling

mkhanfar, 645, Journal Article, , Protective activity of (1S, 2E, 4R, 6R, 7E, 11E)-2, 7, 11-cembratriene-4, 6-diol analogues against diisopropylfluorophosphate neurotoxicity: Preliminary structure–activity relationship and pharmacophore modeling. (2013). Bioorganic & Medicinal Chemistry, 21, 4678–4686.